ECSP961684A - DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICO - Google Patents

DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICO

Info

Publication number
ECSP961684A
ECSP961684A ECSP961684A ECSP961684A EC SP961684 A ECSP961684 A EC SP961684A EC SP961684 A ECSP961684 A EC SP961684A EC SP961684 A ECSP961684 A EC SP961684A
Authority
EC
Ecuador
Prior art keywords
derivatives
acid
hidroxamico
arilsulfonilamino
production
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Ralph Pelton Robinson
James P Rizzi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961684 priority Critical patent/ECSP961684A/en
Publication of ECSP961684A publication Critical patent/ECSP961684A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a derivados delo ácido arilsulfonilamino hidroxímico que son inhibidores de las metas loproteasas de la matriz o de la producción del factor de necrosis tumoral (denominado en lo sucesivo FNT) y, que como tal, son útiles en el tratamiento de un estado seleccionado a partir del grupo que consiste en artritis, cáncer, ulceración tisular, reestenosis, enfermedad periodontal, epidermólisis bullosa, escleritis y otras enfermedades caracterizadas por la actividad de las metaloproteinasas de la matriz, sida, sepsis, choque séptico y otras enfermedades que implican la producción del FNT.The present invention relates to derivatives of arylsulfonylamino hydroxymic acid which are inhibitors of the meta-loprotease targets of the matrix or of the production of tumor necrosis factor (hereinafter referred to as TNF) and which, as such, are useful in the treatment of a status selected from the group consisting of arthritis, cancer, tissue ulceration, restenosis, periodontal disease, epidermolysis bullosa, scleritis, and other diseases characterized by the activity of matrix metalloproteinases, AIDS, sepsis, septic shock, and other diseases involving FNT production.

ECSP961684 1996-03-08 1996-03-08 DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICO ECSP961684A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961684 ECSP961684A (en) 1996-03-08 1996-03-08 DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICO

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961684 ECSP961684A (en) 1996-03-08 1996-03-08 DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICO

Publications (1)

Publication Number Publication Date
ECSP961684A true ECSP961684A (en) 1997-09-22

Family

ID=42042417

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961684 ECSP961684A (en) 1996-03-08 1996-03-08 DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICO

Country Status (1)

Country Link
EC (1) ECSP961684A (en)

Similar Documents

Publication Publication Date Title
AR003935A1 (en) COMPOUND DERIVED FROM ACID ARILSULFONILAMINO HIDROXAMICO, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT AND METHOD FOR ITS PREPARATION.
GT199800025A (en) ARILSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES.
EA199900036A1 (en) METALLIC PROTEASIS INHIBITORS OF MATRIX ON THE BASIS OF PHOSPHINATES, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT
DK0738107T3 (en) Inhibitors of fatty acid synthesis as antimicrobial agents
EP0818442A3 (en) Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor
MX9708026A (en) Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors.
UY27154A1 (en) MATRIX METALOPROTEINASE INHIBITING PYRIMIDINS
EA199900139A1 (en) DERIVATIVES OF ARYL SULPHONYLAMINO HYDROXAMIC ACID
PA8456801A1 (en) DERIVATIVES OF ARILOXIARILSULFONILAMINO HIDROXAMICOS ACIDS
BR0307796A (en) Tricyclic Pyrazole Derivatives for the Treatment of Inflammation
EA199900641A1 (en) Derivatives of arylsulfonylhydroxamic acid
CA2513809A1 (en) Lipophilic derivatives of double-stranded ribonucleic acid
GB9904995D0 (en) Substituted aza-oxindole derivatives
CL2012000609A1 (en) Indenone derived compounds; pharmaceutical composition comprising them, useful for preventing or treating a bone disease selected from osteoporosis, bone growth disorder, bone fractures, periodontal disease, paget's disease, metastatic carcinoma and rheumatoid arthritis.
MX9304501A (en) CHEMOTHERAPY FOR CANCER.
BR0315942A (en) Treatment of diseases and conditions mediated by increased phosphorylation
MXPA03004347A (en) Novel imidazole derivatives, production method thereof and use thereof.
MX2025011764A (en) Modified oligonucleotide for treating polycystic kidney disease
WO2023102377A3 (en) Antisense inhibitors of mir17hg pre-rna as therapeutic agents in cancer
WO2025096970A3 (en) Modified oligonucleotides and methods of use thereof
ECSP961719A (en) DERIVATIVES OF ACID ARIL SULFONIL HIDROXAMICO
WO2023230478A3 (en) Treatment of sos2 related diseases and disorders
ECSP982394A (en) ARILSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES
GT199800029A (en) DERIVATIVES OF N - HYDROXY - B - SULFONILPROPIONAMIDA.
AR003417A1 (en) ARILSULFONIL HYDROXAMIC ACID DERIVATIVES AND COMPOSITION CONTAINING THEM.